SCHEDULE 13D

Company

ORAMED PHARMACEUTICALS INC.

Filed

February 14, 2017

Accession Number

0001213900-17-001320

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →